Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease-Reference-Cited by-同舟云学术

Cell-based therapies for amyotrophic lateral sclerosis/motor neuron disease

Published:2019-12-19 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Abdul Wahid S Fadilah¹,Law Zhe Kang²,Ismail Nor Azimah¹,Lai Nai Ming³

Affiliation:

1. Universiti Kebangsaan Malaysia Medical Centre; Cell Therapy Center; Jalan Yaacob Latif Kuala Lumpur Malaysia 56000

2. Universiti Kebangsaan Malaysia Medical Centre; Department of Medicine, Faculty of Medicine; Kuala Lumpur Malaysia

3. Taylor's University; School of Medicine; Subang Jaya Malaysia

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011742.pub3/epdf/full

Reference108 articles.

1. In vivo modulation of neurotrophic and inflammatory factors in the CSF of ALS patients treated with NurOwn (MSC NTF cells).;Aricha;Cytotherapy,2017

2. Modulation of CSF mirnas in ALS phase 2 study participants treated with MSC-NTF cells (NurOwn);Aricha;Neurology,2018

3. Safety and efficacy of transplantation of NurOwn (autologous mesenchymal stromal cells secreting neurotrophic factors) in patients with ALS: a phase 2 randomized double blind placebo controlled trial;Gothelf;Cryotherapy,2017

4. NurOwn phase 2 ALS trial: ALSFRS-R improvement is reflected in subscale domains;Kern;Neurology,2018

5. NCT02017912 A phase 2, randomised, double blind, placebo controlled multicenter study to evaluate safety and efficacy of transplantation of autologous mesenchymal stem cells secreting neurotrophic factors (MSC-NTF) in patients with ALS clinicaltrials.gov/ct2/show/study/NCT02017912

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics;MedComm;2024-07-28

2. European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERNEURO‐NMD);European Journal of Neurology;2024-03-12

3. Optimal Therapeutic Strategy of Bone Marrow-Originated Autologous Mesenchymal Stromal/Stem Cells for ALS;Stem Cells Translational Medicine;2024-01-19

4. Promising approaches to the pathogenetic therapy of amyotrophic lateral sclerosis;S.S. Korsakov Journal of Neurology and Psychiatry;2024

5. Motor Neuron Disease and Delicate Anesthesia Choices;Motor Neurons - New Insights [Working Title];2023-10-17